Publication Topic
Acute lymphoblastic leukemia (1 POSTS)
2024 (1 POST)
Hernandez L, Davies S, Li C, Reddick E, Jensen I. A cost-consequence analysis of ponatinib versus imatinib in patients with newly diagnosed Philadelphia-positive acute lymphoblastic leukemia in the United States. Abstract EE165. ISPOR 2024 (Top 5% Finalist).
View Abstract